ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 125 filers reported holding ANI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,000 | -50.0% | 54 | -18.2% | 0.00% | – |
| Q2 2020 | $2,000 | -60.0% | 66 | -30.5% | 0.00% | – |
| Q1 2020 | $5,000 | 0.0% | 95 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | +25.0% | 95 | +43.9% | 0.00% | – |
| Q3 2019 | $4,000 | +100.0% | 66 | +94.1% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 34 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 34 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -100.0% | 34 | -100.0% | 0.00% | -100.0% |
| Q2 2017 | $19,708,000 | 0.0% | 398,691 | 0.0% | 0.09% | 0.0% |
| Q1 2017 | $19,708,000 | -14.7% | 398,691 | +4.6% | 0.09% | -25.4% |
| Q4 2016 | $23,097,000 | +160.8% | 381,031 | +185.4% | 0.13% | +152.0% |
| Q3 2016 | $8,856,000 | -6.2% | 133,493 | -44.2% | 0.05% | -27.5% |
| Q3 2015 | $9,445,000 | – | 239,113 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |